Non-pharmacological treatments for pediatric refractory epilepsies.

Epilepsy ketogenic diet neurostimulation non-pharmacological pediatric epilepsy treatments

Journal

Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 24 3 2022
medline: 22 4 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

Antiseizure medications (ASMs) are the primary treatment option for epilepsies of wide etiologies, however, about 10-20% of children do not gain sustained seizure control and in this case, it is worth investigating 'alternative' therapeutic approaches aside from ASMs. Nowadays, non-pharmacological strategies for epilepsy treatment encompass dietary interventions, neurostimulation-based techniques, and biobehavioral approaches. A search on PubMed database was conducted. Experimental and clinical studies, as well as meta-analysis and structured reviews on the latest non-pharmacological treatments for drug-resistant epilepsy (DRE) in children, were included. Special attention is given to the efficacy and tolerability outcomes, trying to infer the role novel approaches may have in the future. The large heterogeneity of primary clinical outcomes and the unavoidable subjective response of each patient to treatments prevents Researchers from the identification of a single, reliable, approach to treat DRE. The understanding of fine pathophysiologic processes is giving the way to the use of alternative therapies, such as the well-known ketogenic diet, in a 'personalized' view of treatment. The goal is to apply the non-pharmacological treatment most suitable for the patient<apos;>s sake.

Identifiants

pubmed: 35320056
doi: 10.1080/14737175.2022.2057847
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

337-349

Auteurs

Eleonora Rotondo (E)

Division of Pediatrics and Neonatology, Ciri Hospital, Torino, Italy.

Antonella Riva (A)

Pediatric Neurology and Muscular Disease Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università degli Studi di Genova, Genova, Italy.

Alessandro Graziosi (A)

ASL Viterbo, Department of Primary Care, Viterbo 01100 via Enrico Fermi 15.

Noemi Pellegrino (N)

Department of Neonatology, National Maternity Hospital, Dublin, Ireland.

Caterina Di Battista (C)

Neonatal Intensive Care Unit,G. D'Annunzio University, Chieti, Italy.

Vincenzo Di Stefano (V)

Department of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, Palermo Italy.

Pasquale Striano (P)

Pediatric Neurology and Muscular Disease Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università degli Studi di Genova, Genova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH